Close Menu
Home
Approach
Team
Careers
News & Publications
Contact
Lausanne
HAYA Therapeutics SA
Route De La Corniche 5B
Batiment Alanine
1066 Epalinges, Lausanne
Vaud, Switzerland
info@hayatx.com
San Diego
HAYA Therapeutics Inc
JLABS
3210 Merryfield Row
San Diego, California 92121
United States
info@hayatx.com
News
The mystery of the human genome's dark matter
April 12, 2023
Read more
News
The mystery of the human genome's dark matter
April 12, 2023
Category
News
Share:
Other news
Nov 4, 2024
News
Reprogramming the software of the cell to fight disease
Read more
Jul 1, 2024
News
HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award
Read more
Sep 6, 2023
News
HAYA Therapeutics wins the top prize at the TOP 100 Swiss Startup Award 2023
Read more
Jul 17, 2023
News
Junk DNA: how the dark genome is changing RNA therapies
Read more
Jan 23, 2023
News
RNA companies to watch over the next 12 months
Read more
Dec 5, 2022
News
Drug discovery startups set to take-off
Read more
Oct 25, 2022
News
Clarivate Identifies Seven Innovators in New RNA Technology Companies to Watch Report
Read more
Sep 29, 2022
News
18 European techbio startups to watch — according to investors
Read more
Sep 27, 2022
News
HAYA Therapeutics: sur la piste de la fibrose
Read more
May 4, 2022
News
What dark matter means for the future of therapeutics
Read more
Apr 11, 2022
News
7 Top BioPharma Startups & Companies (Vaud)
Read more
Oct 28, 2021
News
Delivery & Safety Top Concerns as BIO-Europe Plumbs Future of Gene Therapy
Read more
May 20, 2021
News
HAYA, RenBio Launch with Sights Set on Clinic
Read more
May 20, 2021
News
HAYA Therapeutics raises CHF 18 million Seed financing to advance anti-fibrotic therapies targeting long non-coding RNAs
Read more
May 20, 2021
News
Biotech Haya Therapeutics shouts 'hiya!' as it emerges from stealth with seed funding
Read more
May 20, 2021
News
A new RNA startup looks to reimagine heart treatments, with eyes set on Entresto
Read more